
Research ReportLipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not
Keywords: MPP +; HMG-CoA; 3-hydroxy 3-methyl glutaryl co-enzyme A; MAO; monoamine oxidase; MPP+; 1-methyl-4-phenyl pyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD; Parkinson's disease; PPAR; peroxisome proliferator-activated receptor; ROS; reactive oxyg